Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Schneck

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 1, 1970
Identification of Tay-Sachs disease carriers by acrylamide gel electrophoresisJ Friedland, L Schneck, A Saifer, et al.
Biochimica Et Biophysica Acta|June 19, 1991
SV-40 transformation: effect on GM2 ganglioside in cultured cell linesL M Hoffman, S E Brooks, M R Stein, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1971
Screening for Tay-Sachs disease in utero using amniotic fluidJ Friedland, G Perle, A Saifer, et al.
American Journal of Obstetrics and Gynecology|February 15, 1973
Caveats of antenatal diagnosis of Tay-Sachs diseaseA Saifer, L Schneck, G Perle, et al.
Neurology|October 1, 1974
Fabry's disease in a black man without skin lesionsB W Volk, L Schneck, J E Clemmons, et al.
Acta Neuropathologica|January 1, 1980
Enzyme replacement treatment for Tay-Sachs disease brain cells in culture utilizing concanavalin A-mediated hexosaminidase A uptake: biochemical and morphological evidence of GM2 mobilizationS E Brooks, L M Hoffman, M Adachi, et al.
Journal of Neuroscience Research|January 1, 1981
Long-term intracellular retention of hexosaminidase A by Tay-Sachs disease brain and lung cells in vitroS E Brooks, L M Hoffman, D Amsterdam, et al.
Journal of Cell Science|August 1, 1979
Cytology, growth characteristics and cellular alterations following SV40-induced transformation of human foetal brain cells derived from a Gm2 gangliosidosis and controlS E Brooks, D Amsterdam, L M Hoffman, et al.
Journal of Neurochemistry|March 1, 1970
Cerebral lipids in a case of systemic Gm2-gangliosidosis of a late infantile typeC Klibansky, A Saifer, N I Feldman, et al.
Journal of Neuroscience Research|January 1, 1980
Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase AL M Hoffman, S E Brooks, D Amsterdam, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 1, 1970
Identification of Tay-Sachs disease carriers by acrylamide gel electrophoresisJ Friedland, L Schneck, A Saifer, et al.
Biochimica Et Biophysica Acta|June 19, 1991
SV-40 transformation: effect on GM2 ganglioside in cultured cell linesL M Hoffman, S E Brooks, M R Stein, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1971
Screening for Tay-Sachs disease in utero using amniotic fluidJ Friedland, G Perle, A Saifer, et al.
American Journal of Obstetrics and Gynecology|February 15, 1973
Caveats of antenatal diagnosis of Tay-Sachs diseaseA Saifer, L Schneck, G Perle, et al.
Neurology|October 1, 1974
Fabry's disease in a black man without skin lesionsB W Volk, L Schneck, J E Clemmons, et al.
Acta Neuropathologica|January 1, 1980
Enzyme replacement treatment for Tay-Sachs disease brain cells in culture utilizing concanavalin A-mediated hexosaminidase A uptake: biochemical and morphological evidence of GM2 mobilizationS E Brooks, L M Hoffman, M Adachi, et al.
Journal of Neuroscience Research|January 1, 1981
Long-term intracellular retention of hexosaminidase A by Tay-Sachs disease brain and lung cells in vitroS E Brooks, L M Hoffman, D Amsterdam, et al.
Journal of Cell Science|August 1, 1979
Cytology, growth characteristics and cellular alterations following SV40-induced transformation of human foetal brain cells derived from a Gm2 gangliosidosis and controlS E Brooks, D Amsterdam, L M Hoffman, et al.
Journal of Neurochemistry|March 1, 1970
Cerebral lipids in a case of systemic Gm2-gangliosidosis of a late infantile typeC Klibansky, A Saifer, N I Feldman, et al.
Journal of Neuroscience Research|January 1, 1980
Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase AL M Hoffman, S E Brooks, D Amsterdam, et al.
Pageof 10